Siegall Clay B

President and CEO, DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Dec 22, 2025
Net Buying
Open-Market Buys
$149K
Open-Market Sells
$0
Net Open-Market Flow
$149K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2025Gift(G)200K$0661K
Dec 19, 2025Buy(P)7K$20.48$149K861K

Transaction Codes

G
Gift
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001167496-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly: